SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001615774-18-012549
Filing Date
2018-11-13
Accepted
2018-11-13 16:06:51
Documents
57
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A s113878_10qa.htm 10-Q/A 328115
2 EXHIBIT 31.1 s113878_ex31-1.htm EX-31.1 9112
3 EXHIBIT 31.2 s113878_ex31-2.htm EX-31.2 9172
4 EXHIBIT 32.1 s113878_ex32-1.htm EX-32.1 4624
5 EXHIBIT 32.2 s113878_ex32-2.htm EX-32.2 4549
  Complete submission text file 0001615774-18-012549.txt   2540659

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE atos-20180630.xml EX-101.INS 458304
7 XBRL SCHEMA FILE atos-20180630.xsd EX-101.SCH 30232
8 XBRL CALCULATION FILE atos-20180630_cal.xml EX-101.CAL 44944
9 XBRL DEFINITION FILE atos-20180630_def.xml EX-101.DEF 88525
10 XBRL LABEL FILE atos-20180630_lab.xml EX-101.LAB 236349
11 XBRL PRESENTATION FILE atos-20180630_pre.xml EX-101.PRE 185204
Mailing Address 107 SPRING STREET SEATTLE WA 98104
Business Address 107 SPRING STREET SEATTLE WA 98104 206.588.0256
ATOSSA GENETICS INC (Filer) CIK: 0001488039 (see all company filings)

IRS No.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-35610 | Film No.: 181177967
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1